Fortrea Holdings (FTRE) Accumulated Expenses (2022 - 2026)
Fortrea Holdings (FTRE) posted Accumulated Expenses of $357.3 million for Q1 2026, down 9.73% on a QoQ basis from $395.8 million in Q4 2025, and up 2.91% year-over-year from $347.2 million in Q1 2025.
Fortrea Holdings (FTRE) Accumulated Expenses (2022 - 2026) Analysis & Trends
Fortrea Holdings' Accumulated Expenses history runs 5 years deep, the most recent figure standing at $357.3 million for Q1 2026.
- Quarterly Accumulated Expenses rose 2.91% year-over-year to $357.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $357.3 million (up 2.91% YoY) and the FY2025 annual result came in at $395.8 million, up 7.03% from the prior year.
- Accumulated Expenses was $357.3 million for Q1 2026 at Fortrea Holdings, down from $395.8 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $395.8 million in Q4 2025 and bottomed at $322.7 million in Q4 2022.
- A 5-year average of $349.7 million and a median of $343.3 million in 2024 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2024 — Accumulated Expenses fell 3.78% — and 2025, when it grew 14.39%.
- Fortrea Holdings' Accumulated Expenses stood at $322.7 million in 2022, then grew by 3.97% to $335.5 million in 2023, then gained by 10.22% to $369.8 million in 2024, then increased by 7.03% to $395.8 million in 2025, then fell by 9.73% to $357.3 million in 2026.
- Business Quant data shows FTRE's Accumulated Expenses at $357.3 million in Q1 2026, $395.8 million in Q4 2025, and $369.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 357.30 Mn |
| Dec 31, 2025 | 395.80 Mn |
| Sep 30, 2025 | 369.60 Mn |
| Jun 30, 2025 | 380.80 Mn |
| Mar 31, 2025 | 347.20 Mn |
| Dec 31, 2024 | 369.80 Mn |
| Sep 30, 2024 | 323.10 Mn |
| Jun 30, 2024 | 343.30 Mn |
| Mar 31, 2024 | 328.70 Mn |
| Dec 31, 2023 | 335.50 Mn |
| Sep 30, 2023 | 335.80 Mn |
| Jun 30, 2023 | 336.20 Mn |
| Dec 31, 2022 | 322.70 Mn |